L & S Advisors’s enVVeno Medical NVNO Stock Holding History

L & S Advisors’s Portfolio NVNO Stock Details NVNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-857	Closed	-$311K	–	331
2021 Q3	$311K	Buy	+857	New	+$222K	0.03%	283

Other funds holding NVNO

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

ACT Capital Management Wayne, Pennsylvania $127M AUM

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

L & S Advisors's NVNO Position: Q4 2021 in Review

L & S Advisors sold out of enVVeno Medical (NVNO) in Q4 2021, closing a stake of 857 shares — an estimated $311K sold.

L & S Advisors first reported a position in NVNO in Q3 2021 and held it in 1 quarter. The position peaked at $311K in Q3 2021. 24 funds tracked by Wall St. Rank hold NVNO as of Q4 2021.

L & S Advisors reported no remaining enVVeno Medical position as of Q4 2021 after selling out during the quarter.
L & S Advisors sold 857 enVVeno Medical shares in Q4 2021, an estimated $311K.
L & S Advisors first reported a position in enVVeno Medical in Q3 2021 and held it in 1 quarter.
L & S Advisors's enVVeno Medical position peaked at $311K in Q3 2021.
24 funds tracked by Wall St. Rank held enVVeno Medical as of Q4 2021.

Based on L & S Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.